Form 8-K - Current report:
SEC Accession No. 0000950170-25-103526
Filing Date
2025-08-06
Accepted
2025-08-06 07:03:15
Documents
12
Period of Report
2025-08-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K qttb-20250806.htm   iXBRL 8-K 44936
2 EX-99.1 qttb-ex99_1.htm EX-99.1 220427
3 GRAPHIC img38152436_0.jpg GRAPHIC 7054
  Complete submission text file 0000950170-25-103526.txt   393435

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT qttb-20250806.xsd EX-101.SCH 25023
14 EXTRACTED XBRL INSTANCE DOCUMENT qttb-20250806_htm.xml XML 4727
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 781-999-0232
Q32 Bio Inc. (Filer) CIK: 0001661998 (see all company filings)

EIN.: 473468154 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)